CYRELA REALT (CYRE3) Main Indicators
Company Basic Data| Company | CYRELA REALT |
| Corporate Name | CYRELA BRAZIL REALTY S.A.EMPREEND E PART |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Incorporação Imobiliária |
| Share | CYRE3 |
| Quote Date | 12/02/2024 |
| Share Type | ON |
| Last Closing | R$ 18.28 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 165.27 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Construção Civil |
| Segment | Incorporações |
| Participation Indexes | IBOVESPA, IBRA, IBRX, IBRX50, ICON, IGC, IGCT, IGNM, IMOB, INDX, ISE, ITAG, IVBX, SMLL |
| Updated 12/03/2024 |
Relative Prices, Market Cap, EV, and Dividend Yield | |
|---|
| Price/Earnings | 4.65 |
| Price/SBV | 0.80 |
| Price/Net Sales | 1.00 |
| Price/CFO | -18.90 |
| Price/FCF | -14.48 |
| Price/Total Assets | 0.37 |
| Price/EBIT | 4.28 |
| Price/Working Capital | 0.91 |
| Price/NCAV | -2.61 |
| EV/EBIT | 7.21 |
| EV/EBITDA | 6.94 |
| EV/Net Sales | 1.69 |
| EV/CFO | -31.85 |
| EV/FCF | -24.40 |
| EV/Total Assets | 0.62 |
| Company Market Cap | R$ 7.18 B |
| Enterprise Value | R$ 12.11 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 18.28 |
| Share Price Date | 12/02/2024 |
| Dividend Yield | 5.09% |
Summary Income Statement Last 12 Months | |
|---|
| Net Revenue | R$ 7.17 B |
| Gross Result | R$ 2.36 B |
| EBIT | R$ 1.68 B |
| Depreciation and Amortization | - R$ 65.82 M |
| EBITDA | R$ 1.74 B |
| Net Profit | R$ 1.54 B |
| Net Profit/Share | R$ 3.86 |
Summary Income Statement Last Quarter | |
|---|
| Net Revenue | R$ 2.03 B |
| Gross Result | R$ 676.17 M |
| EBIT | R$ 553.50 M |
| Depreciation and Amortization | - R$ 13.63 M |
| EBITDA | R$ 567.13 M |
| Net Profit | R$ 608.92 M |
| Profit/Share | R$ 1.52 |
Stock Price and Stock Volume Behavior| Lowest Price 52 weeks | R$ 18.28 |
| Highest Price 52 weeks | R$ 24.76 |
| Variation 2024 | -18.69% |
| Variation 1 year | -14.01% |
| Variation 2 years(total) | 35.17% |
| Variation 2 years(yearly) | 16.24% |
| Variation 3 years(total) | 47.76% |
| Variation 3 years(yearly) | 13.89% |
| Variation 4 years(total) | -24.05% |
| Variation 4 years(yearly) | -6.64% |
| Variation 5 years(total) | -11.21% |
| Variation 5 years(yearly) | -2.35% |
| Average Daily Volume (3 months) | R$ 120.93 M |
| Updated 12/03/2024 |
Returns, Margins, and Other Measures | |
|---|
| Return on Initial Tangible Capital | 7.55% |
| Return on Initial Invested Capital | 8.90% |
| Pre-Tax Return on Initial Tangible Capital | 11.44% |
| Pre-Tax Return on Initial Invested Capital | 13.48% |
| Return on Initial Shareholder´s Equity | 19.84% |
| Return on Initial Asset | 9.07% |
| Gross Margin | 32.86% |
| Net Margin | 21.54% |
| EBIT Margin | 23.41% |
| EBITDA Margin | 24.33% |
| Initial Asset Turnover | 0.42 |
| Financial Leverage | 2.19 |
| Liabilities/Net Worth | 1.19 |
| Net Debt/EBITDA | 2.82 |
Summary Balance Sheet | |
|---|
| Cash and Cash Equivalents | R$ 542.67 M |
| Total Assets | R$ 19.57 B |
| Short-Term Debt | R$ 871.36 M |
| Long-Term Debt | R$ 4.59 B |
| Gross Debt | R$ 5.47 B |
| Net Debt | R$ 4.92 B |
| Shareholder´s Equity | R$ 8.94 B |
| Share Book Value | R$ 22.38 |
| Common Shares | 399,743,000 |
| Preferred Shares | 0 |
| Total | 399,743,000 |
| Common Shares in Treasury | 24,822,000 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 24,822,000 |
| Common Shares (Except Treasury) | 374,921,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 374,921,000 |
Summary Cash Flow Statement Last 12 Months | |
|---|
| Operating Cash Flow | - R$ 380.14 M |
| Cash Flow from Investments | R$ 258.95 M |
| Financing Cash Flow | R$ 407.24 M |
| Increase (Reduction) in Cash and Equivalents | R$ 286.05 M |
Summary Cash Flow Statement Last Quarter | |
|---|
| Operating Cash Flow | - R$ 110.54 M |
| Cash Flow from Investments | R$ 219.96 M |
| Financing Cash Flow | R$ 258.07 M |
| Increase (Reduction) in Cash and Equivalents | R$ 367.49 M |
Experimental CAPEX and Free Cash Flow Calculation | |
|---|
| CAPEX 3 months | - R$ 34.02 M |
| Free Cash Flow 3 months | - R$ 144.56 M |
| CAPEX 12 months | - R$ 115.99 M |
| Free Cash Flow 12 months | - R$ 496.12 M |